癌症中的脂质代谢的理论框架和新出现的挑战
Qiuying Gu1, Yuan Wang1, Ping Yi1
1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.
Seminars in cancer biology
|December 14, 2024
概括
癌细胞依赖于改变的脂质代谢来实现生长和增殖. 本综述探讨了脂质代谢和向抗癌疗法的新发现,为未来的研究提供了见解.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 代谢研究研究 代谢研究
背景情况:
- 升高的脂质代谢是恶性瘤的一个关键特征.
- 脂质对癌细胞的增殖,能量和膜结构至关重要.
- 癌细胞精心调节脂质的吸收,合成,运输,储存和代谢.
研究的目的:
- 审查脂质代谢的基本概念及其在癌症中的作用.
- 总结癌症脂质代谢的最新进展,包括新的机制和治疗点.
- 讨论目前针对脂质代谢向抗癌药物的临床前和临床研究.
主要方法:
- 关于癌症脂质代谢的科学文献的系统审查.
- 分析新出现的机制,治疗点和临床研究.
- 讨论未来的研究方向和现场挑战.
主要成果:
- 已经确定了癌症脂质代谢中的新机制和标.
- 针对脂质代谢的药物在临床前和临床研究中显示出有前途.
- 了解脂质代谢对于开发有效的癌症疗法至关重要.
结论:
- 对癌症脂质代谢的持续研究对于推进治疗策略至关重要.
- 准脂质代谢为新型抗癌治疗提供了一个有希望的途径.
- 本综述为癌症脂质代谢研究人员提供了当前的见解和指导.
相关概念视频
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


